These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25771553)

  • 21. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
    [No Abstract]   [Full Text] [Related]  

  • 22. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

  • 23. Surprising ways to cut your drug costs: even with insurance you might be paying too much.
    Consum Rep; 2013 Sep; 78(9):26-30. PubMed ID: 23930299
    [No Abstract]   [Full Text] [Related]  

  • 24. New drugs for old: disinvestment and NICE.
    Hughes DA; Ferner RE
    BMJ; 2010 Feb; 340():c572. PubMed ID: 20185495
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-31. PubMed ID: 28252884
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
    [No Abstract]   [Full Text] [Related]  

  • 27. Value-Based Pricing for Drugs: Theme and Variations.
    Kaltenboeck A; Bach PB
    JAMA; 2018 Jun; 319(21):2165-2166. PubMed ID: 29710320
    [No Abstract]   [Full Text] [Related]  

  • 28. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 29. Public drug expenditure in the Republic of Ireland.
    Barry M; Usher C; Tilson L
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):239-45. PubMed ID: 20545588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-18. PubMed ID: 20213921
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceuticals and Medical Devices: Business Practices.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-38. PubMed ID: 29361660
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceuticals and medical devices: cost savings.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-20. PubMed ID: 19297717
    [No Abstract]   [Full Text] [Related]  

  • 33. The Price of Crossing the Border for Medications.
    Fralick M; Avorn J; Kesselheim AS
    N Engl J Med; 2017 Jul; 377(4):311-313. PubMed ID: 28745989
    [No Abstract]   [Full Text] [Related]  

  • 34. Reducing the burden of medication costs to improve medication adherence.
    Shaw CR
    Nurse Pract; 2014 Jul; 39(7):43-7. PubMed ID: 24932794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. State Remedies For Costly Prescription Drugs.
    Cauchi R
    NCSL Legisbrief; 2018 Aug; 26(29):1-2. PubMed ID: 30199170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
    Bazalo G; Weiss RC
    Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription-drug coupons--no such thing as a free lunch.
    Ross JS; Kesselheim AS
    N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672
    [No Abstract]   [Full Text] [Related]  

  • 38. [The new reference prices: an opportunity for efficient management of medication].
    Ausejo Segura M
    Aten Primaria; 2005 Feb; 35(2):64-6. PubMed ID: 15727746
    [No Abstract]   [Full Text] [Related]  

  • 39. Costs of paying higher prices for equivalent effects on the Pharmaceutical Benefits Scheme.
    Karnon J; Edney L; Sorich M
    Aust Health Rev; 2017 Mar; 41(1):1-6. PubMed ID: 26954612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.